Market Reports
Science and Medicine Group includes market intelligence brands BioInformatics, IMV Medical Information, Kalorama Information, Strategic Directions International, and three Executive Business Outlook Newsletters. Science and Medicine Group plans to publish the following market reports covering the life science, analytical instrument, clinical diagnostic, and diagnostic imaging industries.
Month | Title | Brand | Category | Description |
---|---|---|---|---|
January | Digital Pathology Markets | Kalorama Information | Diagnostics | Competition in the digital pathology market has increased as new automated technologies have come online and IT features are added. This report looks at the essential digital pathology testing market, with marketing sizing and forecasting for scanners, software and storage. Forecasts are to 2027. |
January | World Market for Blood Screening and Typing | Kalorama Information | Diagnostics | The safety of the blood supply is a worldwide concern and IVD technologies have long been employed to help protect blood banks and patients in an increasing amount of countries. This market contains geographic, product (NAT, Immuno, Typing) breakouts of the market and forecasts the market to 2026. Companies are profiled. |
January | World Market for Cardiac Marker Tests | Kalorama Information | Diagnostics | Cardiac marker testing is an area of the IVD market with above average growth traditionally. How are cardiac markers faring in 2022 and beyond. This report looks at the market geographically, by vendor and by type. |
February | Cell and Gene Therapy Deals Analysis | Kalorama Information | Life Sciences, Cell and Gene Therapy | There were nearly 70 Billion Dollars in Deals in 2021. We analyze these deals and look at the science behind it. |
February | Cell and Gene Therapy Market and Market Potential Report | Kalorama Information | Life Sciences, Cell and Gene Therapy | Last year, tens of billions of dollars were invested in the cell and gene therapy market by financial companies and others. But what is the market for these products currently and what's expected in the future? This report charts the expected market for cell and gene therapies in specific areas (oncology, autoimmune, eye disease, cardiology and other markets) and provides insights into the future pipeline. Scores of large and medium-sized cell and gene therapy companies are profiled. |
February | Molecular Point of Care 2021 | Kalorama Information | Diagnostics | This report takes a look at molecular point of care systems and their use in COVID-19, respiratory and other areas. This 2022 edition will be updated with the results of 2021 available at publication time. The report will cover both 'true mPOC’ which is CLIA waived systems and 'near patient' test sales where the mPOC instruments are used for complex testing. Market share is established for both categories. |
February | Veterinary Diagnostic Markets | Kalorama Information | Diagnostics | Veterinary Diagnostics is an important ancillary market for IVD players, and a significant contributor to pet care. While in vitro diagnostic systems are built for specific purposes and there are specialist veterinary diagnostic players, often similar instruments have adaptable qualities with some engineering. This report looks at the market for veterinary diagnostic tests, the forecast and the major players. Geographic breakout is included. |
March | Lab Budgets Survey | Strategic Directions (SDi) | Life Sciences and Analytical Instrumentation | The health of the analytical instrumentation industry is tied directly to the annual investments in research and development made by governments, private industry, and investors. The economic climate, political pressures, societal needs, and technology will affect the outlook for funding all applications, including basic research, drug development, and food production. In light of the global COVID-19 pandemic, lab budgets face major uncertainty in 2022 and beyond. This report offers some clarity in these uncertain times by providing insights gained through a survey of lab personnel with direct knowledge and control of their funding sources, lab budgets and spending plans, representing multiple regions and end markets. |
March | COVID-19 Test Market Update | Kalorama Information | Diagnostics | COVID-19 is increasingly likely to be an endemic test, requiring regular testing and products to support this testing. This report will be one of two updates on COVID-19 as it stands in 2022. |
March | Global Datastream Q4 | Strategic Directions (SDi) | Life Sciences and Analytical Instrumentation | Global Quarterly Datastream provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
March | Infectious Disease World Market Analysis | Kalorama Information | Diagnostics | Infectious diseases make up the largest market for IVD products. Kalorama Information report breaks out infectious disease testing at the country level for significant markets in the world. Tests include: Hepatitis, HIV, COVID-19, Respiratory (Flu/Strep/RSV/Other), STDs, Mycology/TB, Traditional Microbiology and other tests. |
March | IVD Market Update March | Kalorama Information | Diagnostics | This report will update top categories in Kalorama Information's Worldwide Market for In Vitro Diagnostics as they stand in March 2022. |
March | IVD Procedure Volumes | Kalorama Information | Diagnostics | This report provides counts for test procedures in clinical chemistry, hematology, molecular, point of care and other areas. It is based on Kalorama Information's Worldwide Market for In Vitro Diagnostics report. |
March | Molecular Diagnostics Datastream Q4 | Kalorama Information | Diagnostics | Molecular diagnostics is so competitive and fast-growing that our customers desired more frequent updates than our yearly report. The Molecular Diagnostics Datastream, provided with a subscription to Kalorama Information’s diagnostic reports, provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
April | PET Market Summary | IMV Research | Imaging | Based on IMV's PET Census Survey of Hospitals, this 2022 report compares current estimates with results from IMV’s prior PET market reports since 2001 to explore nationwide trends in the volume and type of PET scans performed, manufacturer installed base share, PET scanner installed base characteristics, technology adoption rates, PET scanner purchase plans, radiopharmaceutical utilization, and site operations characteristics such as staffing and productivity. |
April | APAC Markets | Strategic Directions (SDi) | Life Sciences and Analytical Instrumentation | The Asia Pacific (APAC) region, comprising China, India, Japan, Australia, South Korea, and many other countries, has been the fastest growing region for analytical instruments for decades. This report provides a comprehensive analysis of the market, segmented by technique and sector, as well as the competitive landscape. In addition to market demand, this report also features end-user perspectives, gained through a survey of laboratory personnel in the region to provide insights into budgets, spending behavior, government policies, and other factors. |
April | At Home Testing Markets | Kalorama Information | Diagnostics | This report details the market for tests conducted at home by patients over a variety of disease categories. It will look at COVID-19 but also other tests and possible expansion areas in the future. |
April | Worldwide Market for Point of Care | Kalorama Information | Diagnostics | Point of care testing brings tests close to the patient for better care. They have challenges such as cost and IT optimization, but they are increasingly seeing adoption and use in new test segments. This report contains market sizing and forecasts for glucose, colon cancer, pregnancy, COVID-19, HIV, cardiac markers, critical care and other point-of-care test areas. Companies are profiled and venue markets (physician, hospital, other) are provided for the overall POC market. |
May | Single Cell Analysis in Next-Generation Sequencing Markets | Kalorama Information | Life Sciences | This report provides market sizing and projections for the single cell analysis market in genomics. Market share, size, products on the market, future market projections and segmentation are part of this report’s offerings. Segmentation includes market by genomic testing technology, market by consumables and instrumentation, and regional segmentation. |
May | Rx to OTC Switches | Kalorama | Pharmaceutical | What's the market for Rx to OTC Product switches, what brands have successfully switched and what is the growth potential for switches. What are the latest factors driving success |
May | Digital Advertising Survey | BioInformatics | Life Sciences | We've spoken to scientists about the way they purchase products and how they would like to be advertised to. This essential report provides insights into how scientists feel about website marketing and email marketing and is crucial for aligning your marketing with their values. |
May | Histology/Cytology IVD Markets | Kalorama Information | Diagnostics | Histology and cytology procedures are the essential cancer diagnostics. This report covers markets for Pap smears, stains, flow cytometry and other areas. Immunohistochemistry and in situ hybridization are seeing increasing usage. |
May | IVD in India | Kalorama | Diagnostics | The advantage of the Indian market to world IVD manufacturers is that it has a high rate of import of products and a large and growing population to serve. This Kalorama report examines the market with sizing and forecasting. It also looks at the challenges to marketers in India and the intense competition from world players. |
May | IVD in Middle East and Africa | Kalorama Information | Diagnostics | This report looks at a high-growth and essential region for in vitro diagnostic products. |
May | The 2022 Global Assessment for Analytical/Life Sci. Instruments | Strategic Directions (SDi) | Life Sciences | The “gold standard” of market research in the analytical and life science industries. This report features detailed market analysis and growth rates for more than 80 instrument technologies organized into 10 technology categories. Each instrument technique includes data and discussion of market segmentation by product, industry, function, and region. This is the one report relied upon by every major analytical instrument manufacturer. *As an add-on item, the Global Quarterly Datastream provides data updates at the end of each financial quarter throughout the year, including essential data on the importance of currency effects and estimation of organic growth. |
June | HPLC Survey | Strategic Directions (SDi) | Life Sciences and Analytical Instrumentation | What are the next infectious disease challenges that healthcare will be concerned with? What are the markets for tests that are rare but emerging in developed nations? This report covers markets for Lyme, Chagas, Malaria, and other diseases. It also speculates about future disease patterns. |
August | Fixed C Arm | IMV Research | Imaging | Contract manufacturing organizations are essential to the development of cell and gene therapies. There is such a quantity of candidate drugs that outsourcing is needed to avoid bottlenecks. This report covers the market and the key players in this booming industry. |
June | Clinical Lab Services Market, 7th Edition | Kalorama Information | Diagnostics | Molecular diagnostics is so competitive and fast-growing that our customers desired more frequent updates than our yearly report. The Molecular Diagnostics Datastream, provided with a subscription to Kalorama Information’s diagnostic reports, provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
June | Direct to Consumer Genetic Tests | Kalroama | Diagnostics | This report tracks genetic tests ordered by consumers directly or physician assisted but still directed by consumer. Market Sizing, Projections, Company Information and future trends are provided. |
June | US Hospital IVD Instrument Survey | Kalorama Information | Diagnostics | The importance of cell and gene therapy cannot be overstated. This report will continuously update cell and gene therapy clinical trials. |
June | Molecular Diagnostics Datastream Q1 | Kalorama Information | Diagnostics | Molecular diagnostics is so competitive and fast-growing that our customers desired more frequent updates than our yearly report. The Molecular Diagnostics Datastream, provided with a subscription to Kalorama diagnostic reports, provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
June | Nuclear Medicine Market Outlook | IMV Research | Imaging | This report provides insights from radiologists, managers and technicians working with nuclear medicine equipment. It is based on a survey of 200+ hospitals from the IMV database. This report will provide critical insights into system use, vendor preference and buying plans. |
July | Outsourcing in IVD | Kalorama | Diagnostics | To meet growth demands, an increasing amount of IVD products are outsoruced. This report is a unique resource that examines the market for outsourcing IVD products. |
July | Biopharmaceutical Contract Manufacturing Organization (CMO) Market | Kalorama Information | Life Sciences, Cell and Gene Therapy, Pharmaceuticals | Biotech is booming. For one example, cell therapies face a bottleneck in manufacturing. The amount of new candidates often exceeds capacity. This makes cell and gene therapies an interesting area for CMOs. This report looks at the large companies in this space, the market opportunity and other trends. |
July | Emerging Infectious Disease Market Trends | Kalorama Information | Diagnostics | Hospital labs and reference laboratories are a $130 billion-plus industry. This report covers the market for the servicing of tests vs. the equipment (IVD) market. Disease segmentation is made along with type (routine or esoteric), regional breakout and breakout by venue (hospital, reference, other). |
July | Global Datastream Q1 | Strategic Directions (SDi) | Life Sciences and Analytical Instrumentation | Global Quarterly Datastream provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
July | IVD Customer Experience Survey | Kalorama Information | Diagnostics | This report surveys clinical laboratories about their opinion of top IVD vendors in terms of their service and compares with previous years. |
July | IVD in Malaysia, Singapore and Indonesia | Kalorama | Diagnostics | Malaysia, Singapore and Indonesia offer some of the highest market growth opportunities available to mult-national concerns. This report provides segment-level market estimates for the three countries, and covers competition regionally. |
July | SDI Environmental Market Opportunity | Strategic Directions (SDi) | Life Sciences and Analytical Instrumentation | The oil and gas industry as a whole remains the largest single source of energy in terms of global consumption. Fossil fuels, including coal, make up more than 80% of the world’s energy supply. Demand for natural gas is surging. Despite conservation efforts and research into alternative fuel sources, even the most ‘optimistic’ scenarios for reducing global dependence on fossil fuels show oil and gas dominating the energy landscape for many decades. Instrumentation is critical to the exploration, development, production, processing, and delivery of oil and gas products, and it also has crucial roles to play in plant and worker safety, and in the monitoring and testing of fuels. This report evaluates the global analytical instruments market in the oil and gas and other closely related industries, such as environmental testing and monitoring at refineries and utilities/power generation facilities. |
August | Physician Office In Vitro Diagnostic Test Markets | Kalorama | Diagnostics | This report considers the market for in vitro diagnostics that are conducted in the physician office. Market sizing and forecasts are considered. |
August | RNA Sequencing Market | Kalorama Information | Life Sciences | RNA sequencing is an essential application for next-generation sequencers. This report looks at the market for RNA sequencing and profiles key companies in the market. |
August | SDI Installed Base Estimates Report | Strategic Directions (SDi) | Life Sciences and Analytical Instrumentation | In this unique report, Strategic Directions International provides estimates of installed bases for major equipment. For customers seeking to know not just the market for laboratory instruments, but how many instruments there are, SDi is releasing a supplemental spreadsheet deliverable for the 83 analytical technologies covered in the Global Assessment Report 2022. The SDi Installed Base DataFile covers 270 instrument types in total, providing 2021 estimates of average price, unit shipments. |
August | SDI PCR Market and Forecast | Strategic Directions (SDi) | Life Sciences and Analytical Instrumentation | This SDI report will survey PCR users at research laboratories to determine usage, types of experiments, equipment and brand preferences and purchase plans for PCR systems. |
August | The Worldwide Market for In Vitro Diagnostics, 15th Edition | Kalorama Information | Diagnostics | Over 1,000 pages, this report is an essential resource for establishing market opportunity in in vitro diagnostics. Segments include clinical chemistry, immunoassays, molecular and point of care tests. The gold standard of the in vitro diagnostics market, this report details major and minor segments of the market in a global context. |
September | Analytical Instruments Customer Experience* | Strategic Directions (SDi) | Analytical Instrumentation | Appreciating the overall customer experience, from pre-purchase experience, to product experience, to post-purchase experience, is more important now than ever. Customer experience is cited among the top factors affecting analytical instrumentation purchasing decisions, which provides an opportunity for suppliers to differentiate themselves in a crowded marketplace. This report features end-user perspectives gleaned through a survey of laboratory personnel across multiple regions and end markets, to provide insights into customer needs and wants, purchasing behavior, and end-user satisfaction with vendors. |
September | Cell and Gene Therapy Tools, Technologies and Supplies Market | Strategic Directions (SDi) | Life Sciences, Cell and Gene Therapy | Cell & gene therapy (CGT) is a rapidly evolving field producing powerful new treatments for a host of diseases. As development and market entries of CGTs accelerate, opportunities for suppliers of laboratory and clinical tools within the CGT R&D and manufacturing spaces will see very rapid growth. This report details the market for analytical technologies and products used through the various stages of CGT development and manufacturing, providing market size and growth forecasts by technique, region, and function, while also presenting comprehensive views of the competitive landscape. |
September | Life Sciences Customer Experience | BioInformatics | Life Sciences | This report provides the voice of the customer in the life science laboratory. Scientists weigh in on their views regarding specific touchpoints and rank major companies. |
September | Mammography Outlook | IMV Research | Imaging | A Survey of IMV's panel of radiologists for information on Mammography Systems, brands used, procedures conducted, patients visiting, desired replacement... and other information. |
September | Molecular Diagnostics Datastream Q2 | Kalorama Information | Diagnostics | Molecular diagnostics is so competitive and fast-growing that our customers desired more frequent updates than our yearly report. The Molecular Diagnostics Datastream, provided with a subscription to Kalorama diagnostic reports, provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
September | RT Market Summary | IMV Research | Imaging | Based on the IMV Radiation Therapy Census, this report provides useful information and opinions of radiologists and other professionals. The report asks respondents about purchase plans, feature ads, brand loyalty and other questions. |
September | The Market for Medical Devices, 12th Edition | Kalorama | Medical Devices | A complete look at the market for medical devices, including over 50 categories of devices and 40 country medical device markets. |
September | Urgent Care Clinics Market | Kalorama Information | Healthcare | Urgent care has become an important center of healthcare in the U.S., particularly during the COVID-19 crisis. This report covers the business of urgent care and also the sales of IVD, vaccine and other supplies to urgent cares. |
September | Vaccines 2022 | Kalorama | Pharmaceuticals | This report covers the market for vaccines that are both on the market and in development. Segments are Pediatric and Adult vaccines with more than a dozen sub-segments. COVID-19 vaccines are covered, as are new vaccines in development. |
September | World Market for Molecular Diagnostics, 11th, Edition | Kalorama Information | Diagnostics | Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various cancer treatment options, pharmacokinetics or patient metabolism of drugs for HIV, psychiatric conditions or blood thinners; cancer prognosis and therapy, organ matching, blood safety, and the diagnosis of latent and neonatal conditions. Kalorama’s The World Molecular Diagnostics Market, 11th Edition, examines the global market as well as markets by region |
October | AI in Imaging Landscape | IMV Research | Imaging | Of all of the areas where artificial intelligence is expected to influence healthcare, imaging is one of the largest. This is due to the dependence on visual examination, demand for increased procedures and error/cost reduction, and the development of specific computing tools that make AI-guided decisions far more practical. This special report focuses on the key major radiology product offerings. It also analyzes the offerings, PACS compatibility, approval status and technology offerings of 100+ specific AI vendors. |
October | BioPharma Market | Strategic Directions (SDi) | Life Sciences and Analytical Instrumentation | This report provides market analysis focusing specifically on the biopharmaceutical market, covering a wide spectrum of specific product types. The range of products included expands beyond those covered in the Global Assessment report, |
October | COVID-19 Test Market Update | Kalorama Information | Diagnostics | COVID-19 is increasingly likely to be an endemic test, requiring regular testing and products to support this testing. This report will be one of two updates on COVID-19 as it stands in 2022. |
October | IVD Market Update October | Kalorama Information | Diagnostics | This report will update top categories in Kalorama Information's Worldwide Market for In Vitro Diagnostics as they stand in March 2022. |
October | Precision Cancer Therapeutics | Kalorama | Pharmaceuticals | Targeted immunology is one fo the most effective types of cancer therapy and is now part of routine patient management. This report covers market size and forecast for categories of those drugs which are connected with a test so that ideal outcomes can be targeted. Corporate profiles and pipeline analysis are part fo this detailed resource. This is a global market report. |
October | Single Cell Sequencing Survey | BioInformatics | Life Sciences | |
November | CT Market Outlook | IMV Research | Imaging | This report explores nationwide trends in CT procedure volume, manufacturer installed base share, CT equipment features, use of OEM vs. third-party service providers, CT scanner purchase plans, contrast utilization/budgets, CT power injectors, and site operations characteristics. |
November | Oil & Gas Instruments Market Opportunity | Strategic Directions (SDi) | Analytical Instrumentation | Evolving environmental testing regulations continue to alter the landscape for environmental testing and the market for laboratory tools that serve these needs. This market report details specifics about the environmental testing industry, including opportunities and threats facing it from the perspective of instrumentation vendors. Market size and growth for various instrumental techniques are also provided, along with relevant segmentations and vendor share data. |
November | US Market for IVD | Kalorama Information | Diagnostics | This unique report is based on Kalorama Information's Clinical Masterfile, a separate product available from IMV. Kalorama's analysis provides market share based on the IMV conducted survey in various areas, including chemistry immunoassay, hematology and more. The IMV masterfile is a U.S. only focused product, and this report is also focused on the U.S. |
December | Global Datastream Q3 | Strategic Directions (SDi) | Life Sciences and Analytical Instrumentation | Global Quarterly Datastream provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
December | Liquid Biopsy Update | Kalorama Information | Diagnostics | The potential to allow for noninvasive diagnostics operations and successes in efficacy is driving liquid biopsy. This report provides market sizing and potential for a variety of liquid biopsy types |
December | Molecular Diagnostics Datastream Q3 | Kalorama Information | Diagnostics | Molecular diagnostics is so competitive and fast-growing that our customers desired more frequent updates than our yearly report. The Molecular Diagnostics Datastream, provided with a subscription to Kalorama Information’s diagnostic reports, provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
December | MR Market Outlook | IMV Research | Imaging | This report explores nationwide trends in MR procedure volume, manufacturer installed base share, MR equipment features, use of OEM vs. third-party service providers, MR scanner purchase plans, contrast utilization/budgets, MR power injectors, and site operations characteristics. |
Analytical Instrumentation
This content category provides comprehensive market information on 83+ analytical instrumentation technologies, including benchtop laboratory systems, portable instrumentation, and stand-alone instruments used to make analytical determinations. The content provided in this category also covers process instrumentation products and lab software. Ultimately, these reports cover a wide range of topics, such as developed and emerging regional markets, a diverse number of applications from life science to oil and gas, and detailed analysis of specific product categories, such as HPLC or mass spectrometry. In addition to accurate market size and growth data, many of these reports also include end-user perspectives from sizable mar- ket-related surveys covering laboratory budgets, vendor satisfaction, future purchasing plans, and more.
Month | Title | Brand | Description |
---|---|---|---|
March | Lab Budgets Survey | Strategic Directions (SDi) | The health of the analytical instrumentation industry is tied directly to the annual investments in research and development made by governments, private industry, and investors. The economic climate, political pressures, societal needs, and technology will affect the outlook for funding all applications, including basic research, drug development, and food production. In light of the global COVID-19 pandemic, lab budgets face major uncertainty in 2022 and beyond. This report offers some clarity in these uncertain times by providing insights gained through a survey of lab personnel with direct knowledge and control of their funding sources, lab budgets and spending plans, representing multiple regions and end markets. |
March | Global Datastream Q4 | Strategic Directions (SDi) | Global Quarterly Datastream provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
April | APAC Markets | Strategic Directions (SDi) | The Asia Pacific (APAC) region, comprising China, India, Japan, Australia, South Korea, and many other countries, has been the fastest growing region for analytical instruments for decades. This report provides a comprehensive analysis of the market, segmented by technique and sector, as well as the competitive landscape. In addition to market demand, this report also features end-user perspectives, gained through a survey of laboratory personnel in the region to provide insights into budgets, spending behavior, government policies, and other factors. |
June | HPLC Survey | Strategic Directions (SDi) | What are the next infectious disease challenges that healthcare will be concerned with? What are the markets for tests that are rare but emerging in developed nations? This report covers markets for Lyme, Chagas, Malaria, and other diseases. It also speculates about future disease patterns. |
July | Global Datastream Q1 | Strategic Directions (SDi) | Global Quarterly Datastream provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
July | SDI Environmental Market Opportunity | Strategic Directions (SDi) | The oil and gas industry as a whole remains the largest single source of energy in terms of global consumption. Fossil fuels, including coal, make up more than 80% of the world’s energy supply. Demand for natural gas is surging. Despite conservation efforts and research into alternative fuel sources, even the most ‘optimistic’ scenarios for reducing global dependence on fossil fuels show oil and gas dominating the energy landscape for many decades. Instrumentation is critical to the exploration, development, production, processing, and delivery of oil and gas products, and it also has crucial roles to play in plant and worker safety, and in the monitoring and testing of fuels. This report evaluates the global analytical instruments market in the oil and gas and other closely related industries, such as environmental testing and monitoring at refineries and utilities/power generation facilities. |
August | SDI Installed Base Estimates Report | Strategic Directions (SDi) | In this unique report, Strategic Directions International provides estimates of installed bases for major equipment. For customers seeking to know not just the market for laboratory instruments, but how many instruments there are, SDi is releasing a supplemental spreadsheet deliverable for the 83 analytical technologies covered in the Global Assessment Report 2022. The SDi Installed Base DataFile covers 270 instrument types in total, providing 2021 estimates of average price, unit shipments. |
August | SDI PCR Market and Forecast | Strategic Directions (SDi) | This SDI report will survey PCR users at research laboratories to determine usage, types of experiments, equipment and brand preferences and purchase plans for PCR systems. |
September | Analytical Instruments Customer Experience* | Strategic Directions (SDi) | Appreciating the overall customer experience, from pre-purchase experience, to product experience, to post-purchase experience, is more important now than ever. Customer experience is cited among the top factors affecting analytical instrumentation purchasing decisions, which provides an opportunity for suppliers to differentiate themselves in a crowded marketplace. This report features end-user perspectives gleaned through a survey of laboratory personnel across multiple regions and end markets, to provide insights into customer needs and wants, purchasing behavior, and end-user satisfaction with vendors. |
October | Consumables Market or BioPharma Market (TBD)* | Strategic Directions (SDi) | This report provides market analysis focusing specifically on the laboratory consumables market, covering a wide spectrum of specific product types. The range of products included expands beyond those covered in the Global Assessment report, encompassing over 30 product groups across four chapters. Each market brief includes data and discussion on market segmentation by product, industry, function, and region. The report also explores the current state of the competitive playing field for each product group, providing a list of top suppliers and their market share positions. |
November | Oil & Gas Instruments Market Opportunity | Strategic Directions (SDi) | Evolving environmental testing regulations continue to alter the landscape for environmental testing and the market for laboratory tools that serve these needs. This market report details specifics about the environmental testing industry, including opportunities and threats facing it from the perspective of instrumentation vendors. Market size and growth for various instrumental techniques are also provided, along with relevant segmentations and vendor share data. |
December | Global Datastream Q3 | Strategic Directions (SDi) | Global Quarterly Datastream provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
Cell and Gene Therapy
Cell and gene therapies are groundbreaking treatments with the potential to actually cure disease rather than simply manage symptoms. They are often designed as one-time treatments, that in some cases, can actually reverse the progression of an illness. With thousands of potential therapies on the market, cell and gene therapy promises future potential for pharmaceutical developers and those serving them.
Month | Title | Brand | Description |
---|---|---|---|
September | Cell and Gene Therapy Tools, Technologies and Supplies Market | Strategic Directions (SDi) | Cell & gene therapy (CGT) is a rapidly evolving field producing powerful new treatments for a host of diseases. As development and market entries of CGTs accelerate, opportunities for suppliers of laboratory and clinical tools within the CGT R&D and manufacturing spaces will see very rapid growth. This report details the market for analytical technologies and products used through the various stages of CGT development and manufacturing, providing market size and growth forecasts by technique, region, and function, while also presenting comprehensive views of the competitive landscape. |
July | Biopharmaceutical Contract Manufacturing Organization (CMO) Market | Kalorama Information | Biotech is booming. For one example, cell therapies face a bottleneck in manufacturing. The amount of new candidates often exceeds capacity. This makes cell and gene therapies an interesting area for CMOs. This report looks at the large companies in this space, the market opportunity and other trends. |
January | Cell and Gene Therapy Business Outlook | Kalorama Information | With issues 2x a month, this newsletter dedicated to cell and gene therapy is the best way to keep up in this rapidly-developing and well financed field. |
February | Cell and Gene Therapy Market and Market Potential Report | Kalorama Information | Last year, tens of billions of dollars were invested in the cell and gene therapy market by financial companies and others. But what is the market for these products currently and what's expected in the future? This report charts the expected market for cell and gene therapies in specific areas (oncology, autoimmune, eye disease, cardiology and other markets) and provides insights into the future pipeline. Scores of large and medium-sized cell and gene therapy companies are profiled. |
February | Cell and Gene Therapy Deals Analysis | Kalorama Information | There were nearly 70 Billion Dollars in Deals in 2021. We analyze these deals and look at the science behind it. |
Diagnostics
This content category covers many different products, such as molecular assays, immunoassays, point-of-care tests and instruments, infectious dis- ease testing, clinical chemistry, microbiology, virology, lab testing services and providers, associated reagents and clinically-approved instrumentation, and more. Market size and forecasted growth are provided for each information area, as well as detailed information about each market’s history and future trends. Most reports include detailed vendor profiles of both major and minor market players, so subscribers can have a thorough understanding of every aspect of the diagnostics industry.
Month | Title | Brand | Description |
---|---|---|---|
January | Digital Pathology Markets | Kalorama Information | Competition in the digital pathology market has increased as new automated technologies have come online and IT features are added. This report looks at the essential digital pathology testing market, with marketing sizing and forecasting for scanners, software and storage. Forecasts are to 2027. |
January | World Market for Blood Screening and Typing | Kalorama Information | The safety of the blood supply is a worldwide concern and IVD technologies have long been employed to help protect blood banks and patients in an increasing amount of countries. This market contains geographic, product (NAT, Immuno, Typing) breakouts of the market and forecasts the market to 2026. Companies are profiled. |
January | World Market for Cardiac Marker Tests | Kalorama Information | Cardiac marker testing is an area of the IVD market with above average growth traditionally. How are cardiac markers faring in 2022 and beyond. This report looks at the market geographically, by vendor and by type. |
February | Veterinary Diagnostic Markets | Kalorama Information | Veterinary Diagnostics is an important ancillary market for IVD players, and a significant contributor to pet care. While in vitro diagnostic systems are built for specific purposes and there are specialist veterinary diagnostic players, often similar instruments have adaptable qualities with some engineering. This report looks at the market for veterinary diagnostic tests, the forecast and the major players. Geographic breakout is included. |
March | Molecular Point of Care 2022 | Kalorama Information | This report takes a look at molecular point of care systems and their use in COVID-19, respiratory and other areas. This 2022 edition will be updated with the results of 2021 available at publication time. The report will cover both 'true mPOC’ which is CLIA waived systems and 'near patient' test sales where the mPOC instruments are used for complex testing. Market share is established for both categories. |
March | COVID-19 Test Market Update | Kalorama Information | COVID-19 is increasingly likely to be an endemic test, requiring regular testing and products to support this testing. This report will be one of two updates on COVID-19 as it stands in 2022. |
March | Infectious Disease World Market Analysis | Kalorama Information | Infectious diseases make up the largest market for IVD products. Kalorama Information report breaks out infectious disease testing at the country level for significant markets in the world. Tests include: Hepatitis, HIV, COVID-19, Respiratory (Flu/Strep/RSV/Other), STDs, Mycology/TB, Traditional Microbiology and other tests. |
March | IVD Market Update March | Kalorama Information | This report will update top categories in Kalorama Information's Worldwide Market for In Vitro Diagnostics as they stand in March 2022. |
March | IVD Procedure Volumes | Kalorama Information | This report provides counts for test procedures in clinical chemistry, hematology, molecular, point of care and other areas. It is based on Kalorama Information's Worldwide Market for In Vitro Diagnostics report. |
March | Molecular Diagnostics Datastream Q4 | Kalorama Information | Molecular diagnostics is so competitive and fast-growing that our customers desired more frequent updates than our yearly report. The Molecular Diagnostics Datastream, provided with a subscription to Kalorama Information’s diagnostic reports, provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
April | At Home Testing Markets | Kalorama Information | This report details the market for tests conducted at home by patients over a variety of disease categories. It will look at COVID-19 but also other tests and possible expansion areas in the future. |
April | Worldwide Market for Point of Care | Kalorama Information | Point of care testing brings tests close to the patient for better care. They have challenges such as cost and IT optimization, but they are increasingly seeing adoption and use in new test segments. This report contains market sizing and forecasts for glucose, colon cancer, pregnancy, COVID-19, HIV, cardiac markers, critical care and other point-of-care test areas. Companies are profiled and venue markets (physician, hospital, other) are provided for the overall POC market. |
May | Histology/Cytology IVD Markets | Kalorama Information | Histology and cytology procedures are the essential cancer diagnostics. This report covers markets for Pap smears, stains, flow cytometry and other areas. Immunohistochemistry and in situ hybridization are seeing increasing usage. |
May | IVD in India | Kalorama | The advantage of the Indian market to world IVD manufacturers is that it has a high rate of import of products and a large and growing population to serve. This Kalorama report examines the market with sizing and forecasting. It also looks at the challenges to marketers in India and the intense competition from world players. |
May | IVD in Middle East and Africa | Kalorama Information | This report looks at a high-growth and essential region for in vitro diagnostic products. |
June | Clinical Lab Services Market, 7th Edition | Kalorama Information | Molecular diagnostics is so competitive and fast-growing that our customers desired more frequent updates than our yearly report. The Molecular Diagnostics Datastream, provided with a subscription to Kalorama Information’s diagnostic reports, provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
June | Direct to Consumer Genetic Tests | Kalroama | This report tracks genetic tests ordered by consumers directly or physician assisted but still directed by consumer. Market Sizing, Projections, Company Information and future trends are provided. |
June | Molecular Diagnostics Datastream Q1 | Kalorama Information | Molecular diagnostics is so competitive and fast-growing that our customers desired more frequent updates than our yearly report. The Molecular Diagnostics Datastream, provided with a subscription to Kalorama diagnostic reports, provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
June | US Hospital IVD Instrument Survey | Kalorama Information | The importance of cell and gene therapy cannot be overstated. This report will continuously update cell and gene therapy clinical trials. |
July | Contract Manufacturing in IVD | Kalorama | To meet growth demands, an increasing amount of IVD products are outsoruced. This report is a unique resource that examines the market for outsourcing IVD products. |
July | Emerging Infectious Disease Market Trends | Kalorama Information | Hospital labs and reference laboratories are a $130 billion-plus industry. This report covers the market for the servicing of tests vs. the equipment (IVD) market. Disease segmentation is made along with type (routine or esoteric), regional breakout and breakout by venue (hospital, reference, other). |
July | IVD Customer Experience Survey | Kalorama Information | This report surveys clinical laboratories about their opinion of top IVD vendors in terms of their service and compares with previous years. |
July | IVD in Malaysia, Singapore and Indonesia | Kalorama | Malaysia, Singapore and Indonesia offer some of the highest market growth opportunities available to mult-national concerns. This report provides segment-level market estimates for the three countries, and covers competition regionally. |
August | Physician Office In Vitro Diagnostic Test Markets | Kalorama | This report considers the market for in vitro diagnostics that are conducted in the physician office. Market sizing and forecasts are considered. |
August | The Worldwide Market for In Vitro Diagnostics, 15th Edition | Kalorama Information | Over 1,000 pages, this report is an essential resource for establishing market opportunity in in vitro diagnostics. Segments include clinical chemistry, immunoassays, molecular and point of care tests. The gold standard of the in vitro diagnostics market, this report details major and minor segments of the market in a global context. |
September | Molecular Diagnostics Datastream Q2 | Kalorama Information | Molecular diagnostics is so competitive and fast-growing that our customers desired more frequent updates than our yearly report. The Molecular Diagnostics Datastream, provided with a subscription to Kalorama diagnostic reports, provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
September | World Market for Molecular Diagnostics, 11th, Edition | Kalorama Information | Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various cancer treatment options, pharmacokinetics or patient metabolism of drugs for HIV, psychiatric conditions or blood thinners; cancer prognosis and therapy, organ matching, blood safety, and the diagnosis of latent and neonatal conditions. Kalorama’s The World Molecular Diagnostics Market, 11th Edition, examines the global market as well as markets by region |
October | COVID-19 Test Market Update | Kalorama Information | COVID-19 is increasingly likely to be an endemic test, requiring regular testing and products to support this testing. This report will be one of two updates on COVID-19 as it stands in 2022. |
October | IVD Market Update October | Kalorama Information | This report will update top categories in Kalorama Information's Worldwide Market for In Vitro Diagnostics as they stand in March 2022. |
November | US Market for IVD | Kalorama Information | This unique report is based on Kalorama Information's Clinical Masterfile, a separate product available from IMV. Kalorama's analysis provides market share based on the IMV conducted survey in various areas, including chemistry immunoassay, hematology and more. The IMV masterfile is a U.S. only focused product, and this report is also focused on the U.S. |
December | Liquid Biopsy Update | Kalorama Information | The potential to allow for noninvasive diagnostics operations and successes in efficacy is driving liquid biopsy. This report provides market sizing and potential for a variety of liquid biopsy types |
December | Molecular Diagnostics Datastream Q3 | Kalorama Information | Molecular diagnostics is so competitive and fast-growing that our customers desired more frequent updates than our yearly report. The Molecular Diagnostics Datastream, provided with a subscription to Kalorama Information’s diagnostic reports, provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
Healthcare, Digital Health, and Medical Devices
The term “Healthcare” covers many different industries, but this content category focuses on select markets that are seeing the most innovation, upheaval, and transformation. With titles focused on Artificial Intelligence in healthcare, the rise of retail clinics, and connected devices in the Internet of Things, you will be able to understand where the healthcare market has been, where it is now, and where our team of experienced industry analysts expect it to be in the future. Medical Devices is an area that our analysts have also covered for many years, and is included in this content category due to its close relation with the larger healthcare market, such as out-of-pocket expenses and long-term care.
Month | Title | Brand | Description |
---|---|---|---|
September | The Market for Medical Devices, 12th Edition | Kalorama | A complete look at the market for medical devices, including over 50 categories of devices and 40 country medical device markets. |
September | Urgent Care Clinics Market | Kalorama Information | Urgent care has become an important center of healthcare in the U.S., particularly during the COVID-19 crisis. This report covers the business of urgent care and also the sales of IVD, vaccine and other supplies to urgent cares. |
Life Sciences
One of the broadest content categories we offer, our life science market and survey reports supply a broad swath of valuable information. In addition to covering the markets for all analytical instruments used in life science research, also included are survey-based reports with valuable voice-of-the-consumer data covering life science marketing and sales strategies. These reports examine the opinions and preferences of scientists on many different areas of the customer experience, from supplier discovery and awareness, through the purchasing process and post-purchase support. This combination of market and survey data helps subscribers at both the strategic corporate development level and on a more tactical department level.
Month | Title | Brand | Description |
---|---|---|---|
February | Cell and Gene Therapy Deals Analysis | Kalorama Information | There were nearly 70 Billion Dollars in Deals in 2021. We analyze these deals and look at the science behind it. |
February | Cell and Gene Therapy Market and Market Potential Report | Kalorama Information | Last year, tens of billions of dollars were invested in the cell and gene therapy market by financial companies and others. But what is the market for these products currently and what's expected in the future? This report charts the expected market for cell and gene therapies in specific areas (oncology, autoimmune, eye disease, cardiology and other markets) and provides insights into the future pipeline. Scores of large and medium-sized cell and gene therapy companies are profiled. |
March | Lab Budgets Survey | Strategic Directions (SDi) | The health of the analytical instrumentation industry is tied directly to the annual investments in research and development made by governments, private industry, and investors. The economic climate, political pressures, societal needs, and technology will affect the outlook for funding all applications, including basic research, drug development, and food production. In light of the global COVID-19 pandemic, lab budgets face major uncertainty in 2022 and beyond. This report offers some clarity in these uncertain times by providing insights gained through a survey of lab personnel with direct knowledge and control of their funding sources, lab budgets and spending plans, representing multiple regions and end markets. |
March | Global Datastream Q4 | Strategic Directions (SDi) | Global Quarterly Datastream provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
April | Cell Therapy CMO | Kalorama Information | Cell therapies face a bottleneck in manufacturing. The amount of new candidates often exceeds capacity. This makes cell and gene therapies an interesting area for CMOs. This report looks at the large companies in this space, the market opportunity and other trends. |
April | APAC Markets | Strategic Directions (SDi) | The Asia Pacific (APAC) region, comprising China, India, Japan, Australia, South Korea, and many other countries, has been the fastest growing region for analytical instruments for decades. This report provides a comprehensive analysis of the market, segmented by technique and sector, as well as the competitive landscape. In addition to market demand, this report also features end-user perspectives, gained through a survey of laboratory personnel in the region to provide insights into budgets, spending behavior, government policies, and other factors. |
May | Single Cell Analysis in Next-Generation Sequencing Markets | Kalorama Information | This report provides market sizing and projections for the single cell analysis market in genomics. Market share, size, products on the market, future market projections and segmentation are part of this report’s offerings. Segmentation includes market by genomic testing technology, market by consumables and instrumentation, and regional segmentation. |
May | Digital Advertising Survey | BioInformatics | We've spoken to scientists about the way they purchase products and how they would like to be advertised to. This essential report provides insights into how scientists feel about website marketing and email marketing and is crucial for aligning your marketing with their values. |
June | The 2022 Global Assessment for Analytical/Life Sci. Instruments | Strategic Directions (SDi) | The “gold standard” of market research in the analytical and life science industries. This report features detailed market analysis and growth rates for more than 80 instrument technologies organized into 10 technology categories. Each instrument technique includes data and discussion of market segmentation by product, industry, function, and region. This is the one report relied upon by every major analytical instrument manufacturer. *As an add-on item, the Global Quarterly Datastream provides data updates at the end of each financial quarter throughout the year, including essential data on the importance of currency effects and estimation of organic growth. |
June | HPLC Survey | Strategic Directions (SDi) | What are the next infectious disease challenges that healthcare will be concerned with? What are the markets for tests that are rare but emerging in developed nations? This report covers markets for Lyme, Chagas, Malaria, and other diseases. It also speculates about future disease patterns. |
July | Global Datastream Q1 | Strategic Directions (SDi) | Global Quarterly Datastream provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
July | SDI Environmental Market Opportunity | Strategic Directions (SDi) | The oil and gas industry as a whole remains the largest single source of energy in terms of global consumption. Fossil fuels, including coal, make up more than 80% of the world’s energy supply. Demand for natural gas is surging. Despite conservation efforts and research into alternative fuel sources, even the most ‘optimistic’ scenarios for reducing global dependence on fossil fuels show oil and gas dominating the energy landscape for many decades. Instrumentation is critical to the exploration, development, production, processing, and delivery of oil and gas products, and it also has crucial roles to play in plant and worker safety, and in the monitoring and testing of fuels. This report evaluates the global analytical instruments market in the oil and gas and other closely related industries, such as environmental testing and monitoring at refineries and utilities/power generation facilities. |
August | RNA Sequencing Market | Kalorama Information | RNA sequencing is an essential application for next-generation sequencers. This report looks at the market for RNA sequencing and profiles key companies in the market. |
August | SDI Installed Base Estimates Report | Strategic Directions (SDi) | In this unique report, Strategic Directions International provides estimates of installed bases for major equipment. For customers seeking to know not just the market for laboratory instruments, but how many instruments there are, SDi is releasing a supplemental spreadsheet deliverable for the 83 analytical technologies covered in the Global Assessment Report 2022. The SDi Installed Base DataFile covers 270 instrument types in total, providing 2021 estimates of average price, unit shipments. |
August | SDI PCR Market and Forecast | Strategic Directions (SDi) | This SDI report will survey PCR users at research laboratories to determine usage, types of experiments, equipment and brand preferences and purchase plans for PCR systems. |
September | Cell and Gene Therapy Tools, Technologies and Supplies Market | Strategic Directions (SDi) | Cell & gene therapy (CGT) is a rapidly evolving field producing powerful new treatments for a host of diseases. As development and market entries of CGTs accelerate, opportunities for suppliers of laboratory and clinical tools within the CGT R&D and manufacturing spaces will see very rapid growth. This report details the market for analytical technologies and products used through the various stages of CGT development and manufacturing, providing market size and growth forecasts by technique, region, and function, while also presenting comprehensive views of the competitive landscape. |
September | Life Sciences Customer Experience | BioInformatics | This report provides the voice of the customer in the life science laboratory. Scientists weigh in on their views regarding specific touchpoints and rank major companies. |
October | Consumables Market or BioPharma Market (TBD)* | Strategic Directions (SDi) | This report provides market analysis focusing specifically on the laboratory consumables market, covering a wide spectrum of specific product types. The range of products included expands beyond those covered in the Global Assessment report, encompassing over 30 product groups across four chapters. Each market brief includes data and discussion on market segmentation by product, industry, function, and region. The report also explores the current state of the competitive playing field for each product group, providing a list of top suppliers and their market share positions. |
October | Single Cell Sequencing Survey | BioInformatics | |
December | Global Datastream Q3 | Strategic Directions (SDi) | Global Quarterly Datastream provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
Imaging
This content category covers worldwide trends in all major modalities of medical imaging: CT scanners, MR scanners, PET scanners, NM cameras (SPECT-only and SPECT/CT), fixed C-arm systems, fixed general X-ray systems, radiographic fluoroscopy (RF) systems, and more. With almost every report pulling data from a survey of hundreds to thousands of responding imaging centers, you gain access to opinions about the key issues affecting imaging department priorities, challenges, and opportunities. Key topics covered in this category include the relative distribution of the imaging equipment installed base across global regions, manufacturer presence, service satisfaction, purchase plans, total procedure volume, and more.
Month | Title | Brand | Description |
---|---|---|---|
April | PET Market Summary | IMV Research | Based on IMV's PET Census Survey of Hospitals, this 2022 report compares current estimates with results from IMV’s prior PET market reports since 2001 to explore nationwide trends in the volume and type of PET scans performed, manufacturer installed base share, PET scanner installed base characteristics, technology adoption rates, PET scanner purchase plans, radiopharmaceutical utilization, and site operations characteristics such as staffing and productivity. |
June | Fixed C Arm | IMV Research | Contract manufacturing organizations are essential to the development of cell and gene therapies. There is such a quantity of candidate drugs that outsourcing is needed to avoid bottlenecks. This report covers the market and the key players in this booming industry. |
June | Nuclear Medicine Market Outlook | IMV Research | This report provides insights from radiologists, managers and technicians working with nuclear medicine equipment. It is based on a survey of 200+ hospitals from the IMV database. This report will provide critical insights into system use, vendor preference and buying plans. |
September | Mammography Outlook | IMV Research | A Survey of IMV's panel of radiologists for information on Mammography Systems, brands used, procedures conducted, patients visiting, desired replacement... and other information. |
September | RT Market Summary | IMV Research | Based on the IMV Radiation Therapy Census, this report provides useful information and opinions of radiologists and other professionals. The report asks respondents about purchase plans, feature ads, brand loyalty and other questions. |
October | AI in Imaging Landscape | IMV Research | Of all of the areas where artificial intelligence is expected to influence healthcare, imaging is one of the largest. This is due to the dependence on visual examination, demand for increased procedures and error/cost reduction, and the development of specific computing tools that make AI-guided decisions far more practical. This special report focuses on the key major radiology product offerings. It also analyzes the offerings, PACS compatibility, approval status and technology offerings of 100+ specific AI vendors. |
November | CT Market Outlook | IMV Research | This report explores nationwide trends in CT procedure volume, manufacturer installed base share, CT equipment features, use of OEM vs. third-party service providers, CT scanner purchase plans, contrast utilization/budgets, CT power injectors, and site operations characteristics. |
December | MR Market Outlook | IMV Research | This report explores nationwide trends in MR procedure volume, manufacturer installed base share, MR equipment features, use of OEM vs. third-party service providers, MR scanner purchase plans, contrast utilization/budgets, MR power injectors, and site operations characteristics. |
BioInformatics Inc.
BioInformatics Inc., founded in 1994, is a research and advisory firm serving companies in the life science, analytical instrumentation and diagnostics industries for 20+ years. By leveraging our online professional network of nearly 60,000 scientists, The Science Advisory Board®, BioInformatics has supported 500+ companies by providing insights that lead to better business decisions.
Month | Title | Category | Description |
---|---|---|---|
May | Digital Advertising Survey | Life Sciences | We've spoken to scientists about the way they purchase products and how they would like to be advertised to. This essential report provides insights into how scientists feel about website marketing and email marketing and is crucial for aligning your marketing with their values. |
September | Life Sciences Customer Experience | Life Sciences | This report provides the voice of the customer in the life science laboratory. Scientists weigh in on their views regarding specific touchpoints and rank major companies. |
October | Single Cell Sequencing Survey | Life Sciences |
IMV Medical Information
IMV is a recognized leader in market research and online publishing for the medical imaging and clinical diagnostics markets. IMV also offers media properties including Aunt Minnie, the leader in online medical imaging news and radiology CME, and Dr. Bicuspid, the fastest growing dental news and CE digital property.
Month | Title | Category | Description |
---|---|---|---|
April | PET Market Summary | Imaging | Based on IMV's PET Census Survey of Hospitals, this 2022 report compares current estimates with results from IMV’s prior PET market reports since 2001 to explore nationwide trends in the volume and type of PET scans performed, manufacturer installed base share, PET scanner installed base characteristics, technology adoption rates, PET scanner purchase plans, radiopharmaceutical utilization, and site operations characteristics such as staffing and productivity. |
August | Fixed C Arm | Imaging | Contract manufacturing organizations are essential to the development of cell and gene therapies. There is such a quantity of candidate drugs that outsourcing is needed to avoid bottlenecks. This report covers the market and the key players in this booming industry. |
June | Nuclear Medicine Market Outlook | Imaging | This report provides insights from radiologists, managers and technicians working with nuclear medicine equipment. It is based on a survey of 200+ hospitals from the IMV database. This report will provide critical insights into system use, vendor preference and buying plans. |
September | Mammography Outlook | Imaging | A Survey of IMV's panel of radiologists for information on Mammography Systems, brands used, procedures conducted, patients visiting, desired replacement... and other information. |
September | RT Market Summary | Imaging | Based on the IMV Radiation Therapy Census, this report provides useful information and opinions of radiologists and other professionals. The report asks respondents about purchase plans, feature ads, brand loyalty and other questions. |
October | AI in Imaging Landscape | Imaging | Of all of the areas where artificial intelligence is expected to influence healthcare, imaging is one of the largest. This is due to the dependence on visual examination, demand for increased procedures and error/cost reduction, and the development of specific computing tools that make AI-guided decisions far more practical. This special report focuses on the key major radiology product offerings. It also analyzes the offerings, PACS compatibility, approval status and technology offerings of 100+ specific AI vendors. |
November | CT Market Outlook | Imaging | This report explores nationwide trends in CT procedure volume, manufacturer installed base share, CT equipment features, use of OEM vs. third-party service providers, CT scanner purchase plans, contrast utilization/budgets, CT power injectors, and site operations characteristics. |
December | MR Market Outlook | Imaging | This report explores nationwide trends in MR procedure volume, manufacturer installed base share, MR equipment features, use of OEM vs. third-party service providers, MR scanner purchase plans, contrast utilization/budgets, MR power injectors, and site operations characteristics. |
Kalorama Information
Kalorama Information is a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, healthcare, and pharmaceutical industries. Our comprehensive, timely research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of information for top industry decision makers.
Month | Title | Category | Description |
---|---|---|---|
January | Digital Pathology Markets | Diagnostics | Competition in the digital pathology market has increased as new automated technologies have come online and IT features are added. This report looks at the essential digital pathology testing market, with marketing sizing and forecasting for scanners, software and storage. Forecasts are to 2027. |
January | World Market for Blood Screening and Typing | Diagnostics | The safety of the blood supply is a worldwide concern and IVD technologies have long been employed to help protect blood banks and patients in an increasing amount of countries. This market contains geographic, product (NAT, Immuno, Typing) breakouts of the market and forecasts the market to 2026. Companies are profiled. |
January | World Market for Cardiac Marker Tests | Diagnostics | Cardiac marker testing is an area of the IVD market with above average growth traditionally. How are cardiac markers faring in 2022 and beyond. This report looks at the market geographically, by vendor and by type. |
February | Cell and Gene Therapy Deals Analysis | Life Sciences, Cell and Gene Therapy | There were nearly 70 Billion Dollars in Deals in 2021. We analyze these deals and look at the science behind it. |
February | Cell and Gene Therapy Market and Market Potential Report | Life Sciences, Cell and Gene Therapy | Last year, tens of billions of dollars were invested in the cell and gene therapy market by financial companies and others. But what is the market for these products currently and what's expected in the future? This report charts the expected market for cell and gene therapies in specific areas (oncology, autoimmune, eye disease, cardiology and other markets) and provides insights into the future pipeline. Scores of large and medium-sized cell and gene therapy companies are profiled. |
February | Veterinary Diagnostic Markets | Diagnostics | Veterinary Diagnostics is an important ancillary market for IVD players, and a significant contributor to pet care. While in vitro diagnostic systems are built for specific purposes and there are specialist veterinary diagnostic players, often similar instruments have adaptable qualities with some engineering. This report looks at the market for veterinary diagnostic tests, the forecast and the major players. Geographic breakout is included. |
March | Molecular Point of Care 2022 | Diagnostics | This report takes a look at molecular point of care systems and their use in COVID-19, respiratory and other areas. This 2022 edition will be updated with the results of 2021 available at publication time. The report will cover both 'true mPOC’ which is CLIA waived systems and 'near patient' test sales where the mPOC instruments are used for complex testing. Market share is established for both categories. |
March | COVID-19 Test Market Update | Diagnostics | COVID-19 is increasingly likely to be an endemic test, requiring regular testing and products to support this testing. This report will be one of two updates on COVID-19 as it stands in 2022. |
March | Infectious Disease World Market Analysis | Diagnostics | Infectious diseases make up the largest market for IVD products. Kalorama Information report breaks out infectious disease testing at the country level for significant markets in the world. Tests include: Hepatitis, HIV, COVID-19, Respiratory (Flu/Strep/RSV/Other), STDs, Mycology/TB, Traditional Microbiology and other tests. |
March | IVD Market Update March | Diagnostics | This report will update top categories in Kalorama Information's Worldwide Market for In Vitro Diagnostics as they stand in March 2022. |
March | IVD Procedure Volumes | Diagnostics | This report provides counts for test procedures in clinical chemistry, hematology, molecular, point of care and other areas. It is based on Kalorama Information's Worldwide Market for In Vitro Diagnostics report. |
March | Molecular Diagnostics Datastream Q4 | Diagnostics | Molecular diagnostics is so competitive and fast-growing that our customers desired more frequent updates than our yearly report. The Molecular Diagnostics Datastream, provided with a subscription to Kalorama Information’s diagnostic reports, provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
April | At Home Testing Markets | Diagnostics | This report details the market for tests conducted at home by patients over a variety of disease categories. It will look at COVID-19 but also other tests and possible expansion areas in the future. |
April | Single Cell Analysis in Next-Generation Sequencing Markets | Life Sciences | This report provides market sizing and projections for the single cell analysis market in genomics. Market share, size, products on the market, future market projections and segmentation are part of this report’s offerings. Segmentation includes market by genomic testing technology, market by consumables and instrumentation, and regional segmentation. |
April | Worldwide Market for Point of Care | Diagnostics | Point of care testing brings tests close to the patient for better care. They have challenges such as cost and IT optimization, but they are increasingly seeing adoption and use in new test segments. This report contains market sizing and forecasts for glucose, colon cancer, pregnancy, COVID-19, HIV, cardiac markers, critical care and other point-of-care test areas. Companies are profiled and venue markets (physician, hospital, other) are provided for the overall POC market. |
May | Rx to OTC Switches | Pharmaceutical | What's the market for Rx to OTC Product switches, what brands have successfully switched and what is the growth potential for switches. What are the latest factors driving success |
May | Histology/Cytology IVD Markets | Diagnostics | Histology and cytology procedures are the essential cancer diagnostics. This report covers markets for Pap smears, stains, flow cytometry and other areas. Immunohistochemistry and in situ hybridization are seeing increasing usage. |
May | IVD in India | Diagnostics | The advantage of the Indian market to world IVD manufacturers is that it has a high rate of import of products and a large and growing population to serve. This Kalorama report examines the market with sizing and forecasting. It also looks at the challenges to marketers in India and the intense competition from world players. |
May | IVD in Middle East and Africa | Diagnostics | This report looks at a high-growth and essential region for in vitro diagnostic products. |
June | Clinical Lab Services Market, 7th Edition | Diagnostics | Molecular diagnostics is so competitive and fast-growing that our customers desired more frequent updates than our yearly report. The Molecular Diagnostics Datastream, provided with a subscription to Kalorama Information’s diagnostic reports, provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
June | Direct to Consumer Genetic Tests | Diagnostics | This report tracks genetic tests ordered by consumers directly or physician assisted but still directed by consumer. Market Sizing, Projections, Company Information and future trends are provided. |
June | Molecular Diagnostics Datastream Q1 | Diagnostics | Molecular diagnostics is so competitive and fast-growing that our customers desired more frequent updates than our yearly report. The Molecular Diagnostics Datastream, provided with a subscription to Kalorama diagnostic reports, provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
June | US Hospital IVD Instrument Survey | Diagnostics | The importance of cell and gene therapy cannot be overstated. This report will continuously update cell and gene therapy clinical trials. |
July | Contract Manufacturing in IVD | Diagnostics | To meet growth demands, an increasing amount of IVD products are outsoruced. This report is a unique resource that examines the market for outsourcing IVD products. |
July | Biopharmaceutical Contract Manufacturing Organization (CMO) Market | Life Sciences, Cell and Gene Therapy | Biotech is booming. For one example, cell therapies face a bottleneck in manufacturing. The amount of new candidates often exceeds capacity. This makes cell and gene therapies an interesting area for CMOs. This report looks at the large companies in this space, the market opportunity and other trends. |
July | Emerging Infectious Disease Market Trends | Diagnostics | Hospital labs and reference laboratories are a $130 billion-plus industry. This report covers the market for the servicing of tests vs. the equipment (IVD) market. Disease segmentation is made along with type (routine or esoteric), regional breakout and breakout by venue (hospital, reference, other). |
July | IVD Customer Experience Survey | Diagnostics | This report surveys clinical laboratories about their opinion of top IVD vendors in terms of their service and compares with previous years. |
July | IVD in Malaysia, Singapore and Indonesia | Diagnostics | Malaysia, Singapore and Indonesia offer some of the highest market growth opportunities available to mult-national concerns. This report provides segment-level market estimates for the three countries, and covers competition regionally. |
August | Physician Office In Vitro Diagnostic Test Markets | Diagnostics | This report considers the market for in vitro diagnostics that are conducted in the physician office. Market sizing and forecasts are considered. |
August | RNA Sequencing Market | Life Sciences | RNA sequencing is an essential application for next-generation sequencers. This report looks at the market for RNA sequencing and profiles key companies in the market. |
August | The Worldwide Market for In Vitro Diagnostics, 15th Edition | Diagnostics | Over 1,000 pages, this report is an essential resource for establishing market opportunity in in vitro diagnostics. Segments include clinical chemistry, immunoassays, molecular and point of care tests. The gold standard of the in vitro diagnostics market, this report details major and minor segments of the market in a global context. |
September | Molecular Diagnostics Datastream Q2 | Diagnostics | Molecular diagnostics is so competitive and fast-growing that our customers desired more frequent updates than our yearly report. The Molecular Diagnostics Datastream, provided with a subscription to Kalorama diagnostic reports, provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
September | The Market for Medical Devices, 12th Edition | Medical Devices | A complete look at the market for medical devices, including over 50 categories of devices and 40 country medical device markets. |
September | Urgent Care Clinics Market | Healthcare | Urgent care has become an important center of healthcare in the U.S., particularly during the COVID-19 crisis. This report covers the business of urgent care and also the sales of IVD, vaccine and other supplies to urgent cares. |
September | Vaccines 2022 | Pharmaceuticals | This report covers the market for vaccines that are both on the market and in development. Segments are Pediatric and Adult vaccines with more than a dozen sub-segments. COVID-19 vaccines are covered, as are new vaccines in development. |
September | World Market for Molecular Diagnostics, 11th, Edition | Diagnostics | Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various cancer treatment options, pharmacokinetics or patient metabolism of drugs for HIV, psychiatric conditions or blood thinners; cancer prognosis and therapy, organ matching, blood safety, and the diagnosis of latent and neonatal conditions. Kalorama’s The World Molecular Diagnostics Market, 11th Edition, examines the global market as well as markets by region |
October | COVID-19 Test Market Update | Diagnostics | COVID-19 is increasingly likely to be an endemic test, requiring regular testing and products to support this testing. This report will be one of two updates on COVID-19 as it stands in 2022. |
October | IVD Market Update October | Diagnostics | This report will update top categories in Kalorama Information's Worldwide Market for In Vitro Diagnostics as they stand in March 2022. |
October | Precision Cancer Therapeutics | Pharmaceuticals | Targeted immunology is one fo the most effective types of cancer therapy and is now part of routine patient management. This report covers market size and forecast for categories of those drugs which are connected with a test so that ideal outcomes can be targeted. Corporate profiles and pipeline analysis are part fo this detailed resource. This is a global market report. |
November | US Market for IVD | Diagnostics | This unique report is based on Kalorama Information's Clinical Masterfile, a separate product available from IMV. Kalorama's analysis provides market share based on the IMV conducted survey in various areas, including chemistry immunoassay, hematology and more. The IMV masterfile is a U.S. only focused product, and this report is also focused on the U.S. |
December | Liquid Biopsy Update | Diagnostics | The potential to allow for noninvasive diagnostics operations and successes in efficacy is driving liquid biopsy. This report provides market sizing and potential for a variety of liquid biopsy types |
December | Molecular Diagnostics Datastream Q3 | Diagnostics | Molecular diagnostics is so competitive and fast-growing that our customers desired more frequent updates than our yearly report. The Molecular Diagnostics Datastream, provided with a subscription to Kalorama Information’s diagnostic reports, provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
Strategic Directions International
Strategic Directions International (SDi), is a trusted provider of market analyses in the analytical and life science instrumentation industry. Publishers of the industry-renowned Global Assessment Report and Instrument Business Outlook (IBO) publication, the SDi analyst team has decades of experience in both market research and in laboratory settings. SDi understands both the market and the technologies studied.
Month | Title | Category | Description |
---|---|---|---|
March | Lab Budgets Survey | Life Sciences and Analytical Instrumentation | The health of the analytical instrumentation industry is tied directly to the annual investments in research and development made by governments, private industry, and investors. The economic climate, political pressures, societal needs, and technology will affect the outlook for funding all applications, including basic research, drug development, and food production. In light of the global COVID-19 pandemic, lab budgets face major uncertainty in 2022 and beyond. This report offers some clarity in these uncertain times by providing insights gained through a survey of lab personnel with direct knowledge and control of their funding sources, lab budgets and spending plans, representing multiple regions and end markets. |
April | APAC Markets | Life Sciences and Analytical Instrumentation | The Asia Pacific (APAC) region, comprising China, India, Japan, Australia, South Korea, and many other countries, has been the fastest growing region for analytical instruments for decades. This report provides a comprehensive analysis of the market, segmented by technique and sector, as well as the competitive landscape. In addition to market demand, this report also features end-user perspectives, gained through a survey of laboratory personnel in the region to provide insights into budgets, spending behavior, government policies, and other factors. |
March | Global Datastream Q4 | Life Sciences and Analytical Instrumentation | Global Quarterly Datastream provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
May | The 2022 Global Assessment for Analytical/Life Sci. Instruments | Life Sciences | The “gold standard” of market research in the analytical and life science industries. This report features detailed market analysis and growth rates for more than 80 instrument technologies organized into 10 technology categories. Each instrument technique includes data and discussion of market segmentation by product, industry, function, and region. This is the one report relied upon by every major analytical instrument manufacturer. *As an add-on item, the Global Quarterly Datastream provides data updates at the end of each financial quarter throughout the year, including essential data on the importance of currency effects and estimation of organic growth. |
June | HPLC Survey | Life Sciences and Analytical Instrumentation | What are the next infectious disease challenges that healthcare will be concerned with? What are the markets for tests that are rare but emerging in developed nations? This report covers markets for Lyme, Chagas, Malaria, and other diseases. It also speculates about future disease patterns. |
July | Global Datastream Q1 | Life Sciences and Analytical Instrumentation | Global Quarterly Datastream provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
July | SDI Environmental Market Opportunity | Life Sciences and Analytical Instrumentation | The oil and gas industry as a whole remains the largest single source of energy in terms of global consumption. Fossil fuels, including coal, make up more than 80% of the world’s energy supply. Demand for natural gas is surging. Despite conservation efforts and research into alternative fuel sources, even the most ‘optimistic’ scenarios for reducing global dependence on fossil fuels show oil and gas dominating the energy landscape for many decades. Instrumentation is critical to the exploration, development, production, processing, and delivery of oil and gas products, and it also has crucial roles to play in plant and worker safety, and in the monitoring and testing of fuels. This report evaluates the global analytical instruments market in the oil and gas and other closely related industries, such as environmental testing and monitoring at refineries and utilities/power generation facilities. |
August | SDI Installed Base Estimates Report | Life Sciences and Analytical Instrumentation | In this unique report, Strategic Directions International provides estimates of installed bases for major equipment. For customers seeking to know not just the market for laboratory instruments, but how many instruments there are, SDi is releasing a supplemental spreadsheet deliverable for the 83 analytical technologies covered in the Global Assessment Report 2022. The SDi Installed Base DataFile covers 270 instrument types in total, providing 2021 estimates of average price, unit shipments. |
August | SDI PCR Market and Forecast | Life Sciences and Analytical Instrumentation | This SDI report will survey PCR users at research laboratories to determine usage, types of experiments, equipment and brand preferences and purchase plans for PCR systems. |
September | Analytical Instruments Customer Experience* | Analytical Instrumentation | Appreciating the overall customer experience, from pre-purchase experience, to product experience, to post-purchase experience, is more important now than ever. Customer experience is cited among the top factors affecting analytical instrumentation purchasing decisions, which provides an opportunity for suppliers to differentiate themselves in a crowded marketplace. This report features end-user perspectives gleaned through a survey of laboratory personnel across multiple regions and end markets, to provide insights into customer needs and wants, purchasing behavior, and end-user satisfaction with vendors. |
September | Cell and Gene Therapy Tools, Technologies and Supplies Market | Life Sciences, Cell and Gene Therapy | Cell & gene therapy (CGT) is a rapidly evolving field producing powerful new treatments for a host of diseases. As development and market entries of CGTs accelerate, opportunities for suppliers of laboratory and clinical tools within the CGT R&D and manufacturing spaces will see very rapid growth. This report details the market for analytical technologies and products used through the various stages of CGT development and manufacturing, providing market size and growth forecasts by technique, region, and function, while also presenting comprehensive views of the competitive landscape. |
October | Consumables Market or BioPharma Market (TBD)* | Life Sciences and Analytical Instrumentation | This report provides market analysis focusing specifically on the laboratory consumables market, covering a wide spectrum of specific product types. The range of products included expands beyond those covered in the Global Assessment report, encompassing over 30 product groups across four chapters. Each market brief includes data and discussion on market segmentation by product, industry, function, and region. The report also explores the current state of the competitive playing field for each product group, providing a list of top suppliers and their market share positions. |
November | Oil & Gas Instruments Market Opportunity | Analytical Instrumentation | Evolving environmental testing regulations continue to alter the landscape for environmental testing and the market for laboratory tools that serve these needs. This market report details specifics about the environmental testing industry, including opportunities and threats facing it from the perspective of instrumentation vendors. Market size and growth for various instrumental techniques are also provided, along with relevant segmentations and vendor share data. |
December | Global Datastream Q3 | Life Sciences and Analytical Instrumentation | Global Quarterly Datastream provides data updates at the end of each financial quarter throughout the year, including important data on the importance of currency effects and estimation of organic growth. |
Please note: the information in this market intelligence catalog is subject to change.
Want to learn more? Contact Us today to discuss your needs for market insights this year.
About Us
The leading research and advisory firm serving the life science, analytical instrument, diagnostic, healthcare, radiology, and dental industries.
Our Location
671 North Glebe Road, Suite 1610
Arlington, VA 22203
Contact Us
(703) 778-3080
[email protected]
Sitemap